Alzheimers Res Ther. 2009 Jul 9;1(1):2.

Alzheimer's disease therapeutic research: the path forward.

Source

Department of Neurosciences, University of California San Diego, Gilman Drive, La Jolla, CA 92093, USA. paisen@ucsd.edu.

Abstract

The field of Alzheimer's disease therapeutic research seems poised to bring to clinic the next generation of treatments, moving beyond symptomatic benefits to modification of the underlying neurobiology of the disease. But a series of recent trials has had disappointingly negative results that raise questions about our drug development strategies. Consideration of ongoing programs demonstrates difficult pitfalls. But a clear path forward is emerging. Successful strategies will utilize newly available tools to reconsider issues of diagnosis, assessment and analysis, facilitating the study of new treatments at early stages in the disease process at which they are most likely to yield major clinical benefits.

PMID:: 19674435; [PubMed]
PMCID: PMC2719107

Free PMC Article

Publication Types

Editorial

LinkOut - more resources

Full Text Sources

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review [Pharmacology of Alzheimer's disease: where do we go from here?]. [Therapie. 2005]
Review [Pharmacology of Alzheimer's disease: where do we go from here?].
Sellal F, Nieoullon A, Michel G, Michel BF, Lacomblez L, Geerts H, Delini-Stula A, Bentué-Ferrer D, Bordet R, Allain H. Therapie. 2005 Mar-Apr; 60(2):89-107.
Review Disease-modifying trials in Alzheimer's disease: a European task force consensus. [Lancet Neurol. 2007]
Review Disease-modifying trials in Alzheimer's disease: a European task force consensus.
Vellas B, Andrieu S, Sampaio C, Wilcock G, European Task Force group. Lancet Neurol. 2007 Jan; 6(1):56-62.
Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease. [CNS Spectr. 2008]
Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.
Cummings JL, Miller BL, Christensen DD, Cherry D. CNS Spectr. 2008 Feb; 13(2 Suppl 2):1-20; quiz 22.
Review New developments in mild cognitive impairment and Alzheimer's disease. [Curr Opin Neurol. 2006]
Review New developments in mild cognitive impairment and Alzheimer's disease.
Schott JM, Kennedy J, Fox NC. Curr Opin Neurol. 2006 Dec; 19(6):552-8.
Review Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. [Health Technol Assess. 2001]
Review Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N. Health Technol Assess. 2001; 5(1):1-137.

See reviews... See all...

Cited by 4 PubMed Central articles

For debate: substituting placebo controls in long-term Alzheimer's prevention trials. [Alzheimers Res Ther. 2011]
For debate: substituting placebo controls in long-term Alzheimer's prevention trials.
Spiegel R, Berres M, Miserez AR, Monsch AU, the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Res Ther. 2011 Mar 21; 3(2):9. Epub 2011 Mar 21.
Report of the task force on designing clinical trials in early (predementia) AD. [Neurology. 2011]
Report of the task force on designing clinical trials in early (predementia) AD.
Aisen PS, Andrieu S, Sampaio C, Carrillo M, Khachaturian ZS, Dubois B, Feldman HH, Petersen RC, Siemers E, Doody RS, et al. Neurology. 2011 Jan 18; 76(3):280-6. Epub 2010 Dec 22.
Advances in quantitative magnetic resonance imaging-based biomarkers for Alzheimer disease. [Alzheimers Res Ther. 2010]
Advances in quantitative magnetic resonance imaging-based biomarkers for Alzheimer disease.
Dickerson BC. Alzheimers Res Ther. 2010 Jul 6; 2(4):21. Epub 2010 Jul 6.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Alzheimer's disease therapeutic research: the path forward.
Alzheimer's disease therapeutic research: the path forward.
Alzheimers Res Ther. 2009 Jul 9 ;1(1):2.

PubMed
Welcome to Alzheimer's research & therapy.
Welcome to Alzheimer's research & therapy.
Alzheimers Res Ther. 2009 Jul 9 ;1(1):1.

PubMed
Alterations of matrix metalloproteinases in the healthy elderly with increased r...
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease.
Alzheimers Res Ther. 2010 Jun 24 ;2(3):20.

PubMed
Increasing incidence of dementia in the oldest old: evidence and implications.
Increasing incidence of dementia in the oldest old: evidence and implications.
Alzheimers Res Ther. 2010 May 13 ;2(3):9.

PubMed
Pro: Can neuropathology really confirm the exact diagnosis?
Pro: Can neuropathology really confirm the exact diagnosis?
Alzheimers Res Ther. 2010 May 7 ;2(2):10.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Alzheimer's disease therapeutic research: the path forward.

Source

Abstract

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Libraries

Supplemental Content

Related citations

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information